But-x-sha forte tab. of 0.08 g No. 30

Tablets "No-H-sha of ^® forte" are applied at the following indications:

• with the medical purpose at:
  • spasms of smooth muscles connected with diseases of a biliary path: cholecystolithiasis, cholangiolithiasis, cholecystitis, pericholecystitis, cholangitis, papillitis;
  • spasms of smooth muscles at diseases of an uric path: nephrolithiasis, ureterolithiasis, pyelitis, cystitis, bladder tenesmus;
• as auxiliary treatment at:
  • spasms of smooth muscles of digestive tract: a peptic ulcer of a stomach and a duodenum, gastritis, kardio and/or a pylorospasm, enteritis, colitis, a spastic colitis with a constipation and a syndrome of the angry intestines which is followed by a meteorism;
  • a headache of tension;
  • gynecologic diseases (dysmenorrhea).

Structure

Active ingredient - drotaverine (one tablet contains Drotaverinum a hydrochloride in terms of dry matter of 80 mg).

Excipients: lactoses monohydrate, starch corn, magnesium stearate, talc.

Contraindication

• hypersensitivity to Drotaverinum or to any component of medicine;
• heavy liver, renal or heart failure (syndrome of small warm emission;
• medicine "No-H-sha of ^® forte" contains lactose - not to apply to treatment of patients who have rare hereditary diseases, such as intolerance of a galactose, deficiency of Lappa lactases or a sprue of glucose galactose;
• feeding period breast;
• age up to 12 years.

Route of administration

Recommended dosage:

• adult - the usual average dose makes 120-240 mg a day in 2-3 receptions;
• to children is more senior than 12 years - the maximum daily dose makes 160 mg (distributed on ½ tablets 2-4 times a day).

Duration of treatment is defined by the doctor individually depending on character and a course of the disease.

Feature of application

Pregnant

As were shown by results of retrospective clinical trials and researches on animals, oral administration of medicine did not cause any signs of any direct or indirect impact on pregnancy, embryonic development, childbirth or postnatal development. However pregnant women need to appoint medicine with care.

due to the lack of data during feeding.

information on influence of medicine on human fertility.

Drotaverinum Use to children was not estimated by

in clinical trials. Use of medicine for children aged up to 12 years is contraindicated. To apply to children is more senior than 12 years on doctor's orders.

by

Drivers

If after use of medicine observes dizziness, it is necessary to avoid the driving and performance of work requiring special attention.

Overdose

Symptoms: at considerable overdose of Drotaverinum, violations of a warm rhythm and conductivity, including a total block of a ventriculonector and cardiac arrest which can be lethal were observed.

At overdose the patient has to be under careful observation of the doctor and receive symptomatic treatment, including calling of vomiting and/or gastric lavage.

Side effects

Side effects which were observed during clinical trials and, perhaps, were caused by Drotaverinum, distributed on the systems of bodies.

from the immune system: allergic reactions, including a Quincke's disease, a small tortoiseshell, rash, the naggers, a dermahemia, fever, a fever, fervescence, weakness.

from a cardiovascular system: heartbeat, arterial hypotension.

from nervous system: headache, dizziness, insomnia.

from digestive tract: nausea, lock, vomiting.

to Store

in original packing at a temperature not above 25 °C, out of children's reach.

Expiration date - 5 years.